Selective CT for Anticoagulated Head Injured Patients
Condition(s) studied
Study summary
The goal is to derive and a clinical decision rule for safe exclusion of traumatic brain injury without neuroimaging in head-injured ED patients who take anticoagulant medications.
The objectives are to:
1. Derive and externally validate a new highly sensitive and maximally specific clinical decision rule for the exclusion of traumatic brain injury in head-injured ED patients who take anticoagulant medications; and,
2. Estimate the sensitivity and specificity of existing head injury clinical decision rules in head-injured ED patients who take anticoagulant medications.
Eligibility
Primary outcome measure(s)
- Clinically important traumatic brain injury — Index emergency department presentation
Clinically important TBI is defined as the diagnosis of bleeding within the cranial vault, diffuse axonal injury or an isolated skull fracture, which also receives hospital intervention or causes death within 90 days of the traumatic brain injury diagnosis.
Trial sites (7)
| Facility | City | Region | Status |
|---|---|---|---|
| University of British Columbia | Vancouver | British Columbia | Not Yet Recruiting |
| Hamilton Health Sciences Corporation | Hamilton | Ontario | Not Yet Recruiting |
| Kingston Health Sciences Centre | Kingston | Ontario | Recruiting |
| Ottawa Hospital Research Institute | Ottawa | Ontario | Not Yet Recruiting |
| Sinai Health | Toronto | Ontario | Not Yet Recruiting |
| Hôpital du Sacré-Cœur de Montréal | Montreal | Quebec | Not Yet Recruiting |
| CHU de Québec - Université Laval | Québec | Quebec | Not Yet Recruiting |
More Dr. Kerstin de Wit trials in Canada
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05364749 on ClinicalTrials.gov ↗ ← All trials in Canada